IL1B and gastric cancer: These mechanisms result in reduced expression of pro-inflammatory genes such as TNF-α, IL-6, IL-1β, COX-2 and iNOS, highlighting the therapeutic potential of Tan IIA in the treatment of inflammatory and autoimmune diseases, including rheumatoid arthritis, atherosclerosis, neuroinflammation, cardiovascular diseases, and gastric cancer [118,119].